Powered by

Weekly: BioMmune Technologies falls for a second consecutive week, a two-week fall of 13.5% March 03, 2017 17:00 EST

Mar 3, 2017 - News Bites Canadian Markets


BioMmune Technologies Inc. (TSXV:IMU) has fallen 3.0c (or 6.2%) to close at 45.0c. The stock fell for a second consecutive week on Friday bringing its two-week fall to 7.0c or 13.5%. Compared with the S&P/TSX 60 Index which fell 12.8 points (or 1.4%) in the two weeks, this represented a relative price change of -12.1%. The volume was 0.6 times average trading per week of 180,720 shares. In the past two weeks the market cap has slumped CAD2.6 million.


Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox